A TRP Family Based Signature for Prognosis Prediction in Head and Neck Squamous Cell Carcinoma

Figure 2

Predictive value of ARS. (a) The patient outcome of HNSCC. (b) The layout of growing risk scores. (c) Survival analysis for two groups. (d) ROC curves to confirm the performance of TFBS in the training set. (e–l) Present similar results verified in the validation and entire sets.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)